整理 | GLP1减重宝典内容团队俄罗斯制药商Geropharm已获得俄罗斯政府的强制许可,生产由丹麦诺和诺德公司研发的Ozempic(司美格鲁肽)仿制药。据《制药快报》(The Pharma Letter)当地记者报道,与Ozempic一样,Geropharm的仿制药也用于治疗糖尿病和减肥。强制许可的授予意味着Geropharm公司将能够生产其Ozempic的类似物——Semavic和...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.